Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Bioorg Med Chem. 2011 Aug 18;19(19):5861–5868. doi: 10.1016/j.bmc.2011.08.019

Table 1.

Ke values for ring A and N6 analogs at 5-HT2A and α1A receptors

graphic file with name nihms-324120-t0007.jpg

Compd R1 R2 R3 X1 X2 Ke ± SEM (nM)a
5-HT2A α 1A
6a n-Hex Me Me H H 71±19 >10,000
6b Isobu Me Me H H 367±82 >10,000
6c Isopen Me Me H H NDb >10,000
6d 2-EthylBu Me Me H H 806±152 >10,000
6e CyclobutylMe Me Me H H NDb >10,000
6f CyclopentylMe Me Me H H NDb >10,000
6g CyclohexylMe Me Me H H 1722±258 >10,000
6h Allyl Me Me H H 70±15 >10,000
6i HydroxyPr Me Me H H 708±316 >10,000
14a Me Et Me H H 378±92 52±13
14b Me n-Pr Me H H 389±93 133±45
14c Me n-Bu Me H H 943±283 234±52
14d Me n-Pen Me H H >10,000 449±169
14e Me CyclopropylMe Me H H 484±123 195±86
14f Me Benzyl Me H H 154±76 1917±226
15 Me Me Me Br H 53±14 >10,000
16 Me Me Me Br Br 43±11 >10,000
18a Me Me Et H H >10,000 26±6
18b Me Me n-Pr H H >10,000 38±3
18c Me Me n-Bu H H >10,000 210±50
18d Me Me n-Pen H H >10,000 720±204
18e Me Me CyclopropylMe H H >10,000 319±60
2 Me Me Me H H 850±6c 36±7
prazosin 1.1 ± 0.4
ketanserin 32c,d
a

Values represent mean ± SEM for three independent experiments.

b

ND = Ke not determined (compounds were weak agonists).

c

Data from reference 25

d

IC50 determined in the presence of 5-HT EC80